Protective effects of 17beta-estradiol on post-ischemic cardiac dysfunction and norepinephrine overflow through the non-genomic estrogen receptor/nitric oxide-mediated pathway in the rat heart.

@article{Fukumoto2013ProtectiveEO,
  title={Protective effects of 17beta-estradiol on post-ischemic cardiac dysfunction and norepinephrine overflow through the non-genomic estrogen receptor/nitric oxide-mediated pathway in the rat heart.},
  author={Taiki Fukumoto and Masashi Tawa and Naoto Yamashita and Mamoru Ohkita and Yasuo Matsumura},
  journal={European journal of pharmacology},
  year={2013},
  volume={699 1-3},
  pages={
          74-80
        }
}
The present study was undertaken to examine the effect of acute treatment with 17β-estradiol on post-ischemic cardiac dysfunction and norepinephrine overflow and its possible mechanisms. Male rat hearts were perfused with the Langendorff method and subjected to 40 min of global ischemia followed by 30 min of reperfusion. Each drug was perfused from 15 min before ischemia to 5 min after reperfusion. During reperfusion, 17β-estradiol treatment showed significantly greater functional recovery of… Expand
Nonylphenol disrupts the cardio-protective effects of 17β-estradiol on ischemia/reperfusion injury in isolated hearts of guinea pig.
TLDR
NP had direct toxic effects on normal hearts and NP might disrupt the cardio-protective effects of E₂ on I/R injury, and these data demonstrate that NP was toxic to isolated healthy hearts. Expand
The mKATP channels and PKC are involved in the cardioprotective effects of genistein on estrogen-deficient rat hearts exposed to ischemia/reperfusion: energetic study.
TLDR
Results suggest that Estrogenic deficiency worsens cardiac stunning, and GST-ip was more cardioprotective in estrogenic deficiency and synergistic with estradiol, which depends on the PKC and mKATP channels pathway activation. Expand
Estrogenic Impact on Cardiac Ischemic/Reperfusion Injury
TLDR
The effects of estrogen, in both acute and chronic treatment, are reviewed and studies with regard to their in vivo, in vitro, or clinical trial settings in cases of cardiac I/R injury and myocardial infarction are collated. Expand
N-acetylcysteine with low-dose estrogen reduces cardiac ischemia-reperfusion injury.
TLDR
Combined NAC with low-dose estrogen and regular- dose estrogen therapy similarly improve cardiometabolic function, prevent cardiac mitochondrial dysfunction and reduces the infarct size in estrogen-deprived rats with cardiac I/R injury. Expand
Sex differences in the mechano‐energetic effects of genistein on stunned rat and guinea pig hearts
TLDR
Results suggest that Gen acts on several mechanisms that regulate myocardial calcium homeostasis and energetics during I/R, which differ in a temperature‐ and sex‐dependent manner. Expand
Non-genomic Effects of Estrogen on Cell Homeostasis and Remodeling With Special Focus on Cardiac Ischemia/Reperfusion Injury
TLDR
This review takes into consideration the main mechanisms involved in cellular remodeling following an ischemic injury, with special focus on the possible role played by non-genomic estrogen effects, and a role for estrogen in this sex disparity has been hypothesized. Expand
Nonylphenol disrupts the cardioprotective effects of hearts of guinea pig
genic properties. However, its cardiac effects remain unclear. In this study, the effects of NP on isolated guinea pig hearts were studied in three separate experiments. First, hearts were perfusedExpand
The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.
TLDR
The beneficial effects of estrogen in protecting the cardiovascular system through ER-dependent mechanisms with an emphasis on the role of the recently described ER membrane signaling mechanisms are summarized. Expand
Gender and Cardiovascular Disease in the Post-Genomic Era
TLDR
There is growing evidence that epigenetic and environmental factors play a role in the persistent and heritable changes in the developing fetus that contribute to the etiology of cardiac diseases that might develop in adulthood and might be involved in the sexual dimorphism of several cardiac diseases. Expand
An in-vivo Investigation of the CardioProtective Potential of Aspirin , β-oestradiol and Calcipotriol for Trastuzumab Treatment of Her-2 Positive Breast Cancer
The 15-25% of breast cancers that overexpress human epidermal growth factor receptor type 2 (Her-2) are aggressive and more difficult to treat with conventional chemotherapy than their oestrogenExpand
...
1
2
...

References

SHOWING 1-10 OF 51 REFERENCES
Sex Differences in Postischemic Cardiac Dysfunction and Norepinephrine Overflow in Rat Heart: The Role of Estrogen Against Myocardial Ischemia–reperfusion Damage Via an NO-mediated Mechanism
TLDR
It is suggested that estrogen plays a key role in the cardioprotective effect against I/R injury in female rats, by suppressing NE release via the enhancement of NO production. Expand
Amelioration of ischemia- and reperfusion-induced myocardial injury by 17beta-estradiol: role of nitric oxide and calcium-activated potassium channels.
TLDR
Both myocardial infarct size and the occurrence of ischemia- and reperfusion-induced ventricular arrhythmias, which appear to be mediated by NO and the opening of K(Ca) channels in canine hearts, were reduced in the 17beta-estradiol group. Expand
Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
TLDR
Cardiac endothelin-1 production is enhanced by ischemia/reperfusion, and this endogenously increased endotheli-1 is involved in post-ischemic norepinephrine overflow and cardiac dysfunction via the activation of endothelins ET(A) receptors. Expand
Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury.
TLDR
The GPR30 agonist, G-1, improves functional recovery and decreases myocardial inflammation after global ischemia/reperfusion (I/R) in male Sprague-Dawley rats. Expand
Role of Histamine H3 Receptors during Ischemia/Reperfusion in Isolated Rat Hearts
TLDR
It seems likely that the ischemia/reperfusion-induced carrier-mediated NE release in rat hearts is negatively regulated by the activation of H3 receptors, probably located on cardiac noradrenergic nerve endings. Expand
Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat.
TLDR
E2 replacement in ovariectomized rats improves contractile function following global ischemia and reflow; cardioprotection by estrogen was observed over and above that conferred by ischemic preconditioning. Expand
The Pathway-selective Estrogen Receptor Ligand WAY-169916 Displays Differential Activity in Ischemia-Reperfusion Injury Models
TLDR
The data demonstrate that the pathway-selective ER ligand WAY-169916 displays differential activity in vivo on different cardiovascular end points in models of cardiac ischemia-reperfusion injury. Expand
17Beta-estradiol as a receptor-mediated cardioprotective agent.
TLDR
The results indicate that 17beta-estradiol protects the heart against ischemia-reperfusion injury and that the observed cardioprotection is mediated by the estrogen receptor. Expand
Postconditioning Improves Postischemic Cardiac Dysfunction Independently of Norepinephrine Overflow After Reperfusion in Rat Hearts: Comparison With Preconditioning
TLDR
Findings indicate that the beneficial effect of postC on I/R-induced cardiac dysfunction depends on nitric oxide and is irrelevant to NE overflow after reperfusion in contrast to the preC effect. Expand
17β-Estradiol as a Receptor-Mediated Cardioprotective Agent
TLDR
The results indicate that 17β-estradiol protects the heart against ischemia-reperfusion injury and that the observed cardioprotection is mediated by the estrogen receptor. Expand
...
1
2
3
4
5
...